Vaccines and methods for using the same
AssigneeThe Trustees of the University of Pennsylvania
InventorsDavid B Weiner, Jian Yan, Dominick Laddy
Life of this patent
Estimating the term…
Loading patent…
AssigneeThe Trustees of the University of Pennsylvania
InventorsDavid B Weiner, Jian Yan, Dominick Laddy
Estimating the term…
Improved anti-HIV immunogens and nucleic acid molecules that encode them are disclosed, Immunogens disclosed include those having consensus sequences for HIV Subtype A Envelope protein, those having consensus sequences for HIV Subtype B Envelope protein, those having consensus sequences for HIV Subtype C Envelope protein, those having consensus sequences for HIV Subtype D Envelope protein, those having consensus sequences for HIV Subtype B consensus Nef-Rev protein, and those having consensus sequences form HIV Gag protein subtypes A, B, C and D. Improved anti-HPV immunogens and nucleic acid molecules that encode them; improved anti-HCV immunogens and nucleic acid molecules that encode them; improved hTERT immunogens and nucleic acid molecules that encode them; and improved anti-Influenza immunogens and nucleic acid molecules that encode them are disclosed. Pharmaceutical composition, recombinant vaccines comprising and live attenuated pathogens are disclosed as well methods of inducing an immune response in an individual against HIV, HPV, HCV, hTERT and Influenza are disclosed.
A nucleic acid molecule comprising a nucleotide sequence selected from the group consisting of:
A nucleic acid molecule comprising a nucleotide sequence selected from the group consisting of:
A protein comprising an amino acid sequence selected from the group consisting of:
Dependencies are inferred from the claim text.